Tron - Translationale Onkologie Ander Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH

Tron - Translationale Onkologie Ander Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH is a research organisation in Mainz, Germany that has taken part in 7 EU-funded projects since 2013, receiving €4.1M in EU funding and leading 2 as coordinator.

EU funding received€4.1M
EU projects7
As coordinator2
Running now2
First EU project2013
Latest project2026
CountryGermany
EU registration (PIC)959576381
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Tron - Translationale Onkologie Ander Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH's own share of each project, not the project's full budget.

  • Horizon 2020€2.8M · 3 projects
  • Horizon Europe€1.2M · 2 projects
  • FP7 (2007 to 2013)€100k · 1 project
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

7 EU-funded projects, newest first. Tron - Translationale Onkologie Ander Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH led 2 of them as coordinator. Each links to the official record.

  • ARISEPartner

    Advanced platform for saRNA production at Industrial Scale in Eukaryotes

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €716ktheir share
  • LIVE_InnovAssociated partner

    Leading International Vaccinology Education for Innovation

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • YscriptPartner

    Yeast cell factory for mRNA bioproduction

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €492ktheir share
  • TICARDIOPartner

    Thrombo-inflammation in cardiovascular disease

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  • SUMMITCoordinator

    Stepping Up mRNA Mutanome Immunotherapy

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €2.5Mtheir share
  • APERIMPartner

    APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €347ktheir share
  • SCA4PCVCoordinator

    Single cell analysis of tumor cells for personalized cancer vaccines

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €100ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • arteriosclerosis
  • biophysics
  • chemical engineering
  • colorectal cancer
  • drug discovery
  • evolutionary biology
  • immunotherapy
  • inflammatory diseases
  • molecular biology
  • mutation
  • oncology
  • pathology
  • semantic web

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime